Express Scripts may not be allowed to merge with Medco, but Walgreen's latest earnings report shows that drugstores are the real losers. Read More

Warren Buffett's new-found interest in Japanese stocks is directly related to their historic cheapness. Simply put, Japan is a value investor's dream. Read More

Congress averted a government shutdown in a rare moment of bipartisan action. But US politics will continue to exert an outsized influence on markets in 2012. Here’s how to protect yourself from uncertainty in Washington. Read More

TransCanada Corp (TSX: TRP, NYSE: TRP) is adding a lane and expanding capacity to its Keystone XL project, with the firm backing of its customers. Read More

First Solar's lowered sales guidance causes its stock to drop more than 20% in a single day, but the solar energy stock remains profitable and is no Solyndra. Read More

Contrarian plays have a mixed record of delivering profits to investors. But January is historically a strong month for contrarian trades, and we believe one sector will surprise investors in 2012. Read More

Despite all the headwinds facing the US economy, our nation benefits from one major advantage over other developed nations: lower energy prices. Read More

When investing in IPOs, one needs to know how to separate the wheat from the chaff. Jim only likes two of this week's IPOs, which include the long-awaited Zynga. To find out which two IPOs may be worth your investment dollars, read on. Read More

Foreign retailers have experienced another setback in India. But several US-listed Indian companies will allow investors to tap into the rapid growth of India’s consumer culture. Read More

The U.S. economy is strengthening. Or is it? Sometimes the light at the end of the tunnel is an oncoming train. Read More